Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Ippokratis Pountos & Peter V. Giannoudis. (2018) Drug-eluting implants for the suppression of metastatic bone disease: current insights. Expert Review of Medical Devices 15:4, pages 301-311.
Read now
Read now
Allan Lipton. (2003) Bisphosphonate therapy in the oncology setting. Expert Opinion on Emerging Drugs 8:2, pages 469-488.
Read now
Read now
Articles from other publishers (17)
Stéphane Oudard & Álvaro Juárez Soto. (2019) A Multi-Disciplinary Review of the Evidence Supporting Metastasis-Free Survival (MFS) and the Benefit of Delaying Metastasis in High-Risk Non-Metastatic Castration-Resistant Prostate Cancer (nmCRPC). EMJ Urology, pages 2-11.
Crossref
Crossref
Stein J. Janssen, Teun Teunis, Francis J. Hornicek, C. Niek van Dijk, Jos A.M. Bramer & Joseph H. Schwab. (2016) Outcome after fixation of metastatic proximal femoral fractures: A systematic review of 40 studies. Journal of Surgical Oncology 114:4, pages 507-519.
Crossref
Crossref
Martin H. Hessmann & Pol M. Rommens. 2015. Intramedullary Nailing. Intramedullary Nailing
543
554
.
Rüdiger J. Weiss, Wilhelmina Ekström, Bjarne H. Hansen, Johnny Keller, Minna Laitinen, Clement Trovik, Olga Zaikova & Rikard Wedin. (2012) Pathological subtrochanteric fractures in 194 patients: A comparison of outcome after surgical treatment of pathological and non‐pathological fractures. Journal of Surgical Oncology 107:5, pages 498-504.
Crossref
Crossref
Ajay Malviya & Craig Gerrand. (2011) Evidence for orthopaedic surgery in the treatment of metastatic bone disease of the extremities: A review article. Palliative Medicine 26:6, pages 788-796.
Crossref
Crossref
Luis Costa & Pierre P Major. (2009) Effect of bisphosphonates on pain and quality of life in patients with bone metastases. Nature Reviews Clinical Oncology 6:3, pages 163-174.
Crossref
Crossref
Hafiz Javaid Iqbal & Mark Webb. (2008) A Novel Use of Flexible Intramedullary Nails in Pathological Forearm Fractures. Techniques in Shoulder and Elbow Surgery 9:3, pages 148-150.
Crossref
Crossref
Fred Saad & Allan Lipton. 2008. Renal Cell Cancer. Renal Cell Cancer
505
514
.
Richard KhafagyDavid ShackleyJoanne SamuelKieran O'FlynnChris BettsNoel Clarke. (2007) Complications Arising in the Final Year of Life in Men Dying from Advanced Prostate Cancer. Journal of Palliative Medicine 10:3, pages 705-711.
Crossref
Crossref
D. Biau & P. Anract. (2007) Fractures sur os pathologique. EMC - Appareil locomoteur 2:4, pages 1-14.
Crossref
Crossref
Fred Saad, Noel Clarke & Marc Colombel. (2006) Natural History and Treatment of Bone Complications in Prostate Cancer. European Urology 49:3, pages 429-440.
Crossref
Crossref
Fred Saad, Carl Olsson & Claude C. Schulman. (2004) Skeletal Morbidity in Men with Prostate Cancer: Quality-of-Life Considerations throughout the Continuum of Care. European Urology 46:6, pages 731-740.
Crossref
Crossref
E. David Crawford. (2004) Skeletal Complications in Men with Prostate Cancer: Effects on Quality-of-Life Outcomes throughout the Continuum of Care. European Urology Supplements 3:5, pages 10-15.
Crossref
Crossref
Paul A. Kvale, Michael Simoff & Udaya B.S. Prakash. (2003) Palliative Care*. Chest 123:1, pages 284S-311S.
Crossref
Crossref
Fred Saad. (2002) Zoledronic Acid Significantly Reduces Pathologic Fractures in Patients with Advanced-Stage Prostate Cancer Metastatic to Bone. Clinical Prostate Cancer 1:3, pages 145-152.
Crossref
Crossref
Lee Rosen, Stephen J. Harland & Willem Oosterlinck. (2002) Broad Clinical Activity of Zoledronic Acid in Osteolytic to Osteoblastic Bone Lesions in Patients With a Broad Range of Solid Tumors. American Journal of Clinical Oncology 25, pages S19-S24.
Crossref
Crossref
S.A Edwards, H.G Pandit & H.J Clarke. (2001) The treatment of impending and existing pathological femoral fractures using the long gamma nail. Injury 32:4, pages 299-306.
Crossref
Crossref